Internally Irrigated and Externally Irrigated Surgical Guide Design for Placement of Dental Endosseous Implants
Evaluation of Internally Irrigated and Externally Irrigated Surgical Guide Design for Placement of Dental Endosseous Implants in Mandibular Posterior Region (Randomized Controlled Clinical Trial)
1 other identifier
interventional
14
1 country
1
Brief Summary
Background: Patient specific surgical guides (PSG) have been widely used to achieve a precise 3D implant position. However, they prevent external cooling systems from reaching the osteotomy site sufficiently. So, heat generated during guided implant surgery is greater than free hand technique. Adding internal irrigation channel to the conventional surgical guides allows better diffusion of irrigation to the osteotomy site and reduces heat generation. Aim of the study: Is to introduce a patient specific surgical guide design with internal irrigation system and compare it to the conventional surgical guide with external irrigation clinically through bone temperature, implant stability and radiographically by CBCT through crestal bone loss and bone density.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2024
CompletedFirst Submitted
Initial submission to the registry
March 2, 2025
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedMarch 10, 2025
March 1, 2025
7 months
March 2, 2025
March 6, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
change in implant stability
Osstell will be used to objectively and non-invasively determine implant stability and to assess the progress of osseointegration without jeopardizing the healing process. This method is based on determining whether or not an implant is stable enough. The result is presented as an ISQ value of 1-100. The higher the ISQ, the more stable the implant
Baseline and 4 months
change in postoperative oedema
This will be measured as follows: None (no inflammation). Mild (intraoral swelling confined to the surgical field). Moderate (extraoral swelling in the surgical zone). Severe (extraoral swelling spreading beyond the surgical zone).
2nd day, 1 week and 2 weeks
Secondary Outcomes (3)
Presence of intra or postoperative complications
4 months
change in crestal bone loss
baseline and 4 months
change in bone density
baseline and 4 months
Study Arms (2)
Study group
EXPERIMENTALControl group
ACTIVE COMPARATORInterventions
* Virtual surgical plan will be completed in the implant planning software (BlueSky plan, BlueSky Bio, USA), and the implant type, position, and sleeve height will be adjusted. * The entry point of the surgical drill into the alveolar bone will be identified. * An irrigation channel will be added, directed toward the entry point of the drill and adjusted to have the same diameter as the irrigation system tube.
Virtual surgical plan will be completed in the implant planning software (BlueSky plan, BlueSky Bio, USA), and the implant type, position, and sleeve height will be adjusted. Conventional guide will be printed
Eligibility Criteria
You may qualify if:
- Patient with missing mandibular posterior premolar or molar teeth.
- Tooth extraction at the implant sites was performed at least 4 months before the surgery.
- Residual alveolar bone height more than 10 mm.
- With minimum alveolar bucco-lingual dimension of 6 mm.
- Free from any systemic disease or local pathological lesions that may affect bone healing or contraindicate implant placement.
You may not qualify if:
- Severe atrophic alveolar ridge (height less than 10mm, width less than 6mm).
- Bad oral hygiene ( Silness-Löe index (score 2-3).
- Heavy smoker (smoke greater than or equal 25 cigarettes per day).
- Presence of acute infections or periapical lesions in adjacent teeth.
- Parafunctional habits.
- Pregnant females.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Egypt
Alexandria, Azarita, 00203, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Lecturer of Dental Public Health and biostatistical consultanat
Study Record Dates
First Submitted
March 2, 2025
First Posted
March 10, 2025
Study Start
April 4, 2024
Primary Completion
October 17, 2024
Study Completion
October 17, 2024
Last Updated
March 10, 2025
Record last verified: 2025-03